ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 569,17
-0,83%
Dow Jones
40 211,72
0,00%
DAX
18 483,03
-0,63%
Brent Oil
82,94
-1,66%
Bitcoin
63 750,25
-1,70%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Allos Therapeutics, Inc. (MM) (ALTH)

  7. Allos Therapeutics, Inc. (MM) (ALTH) Actualités

ALTH

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ALTH
DateHeureSourceTitreSymboleSociété
03/12/200914h00Business WireAllos Therapeutics to Launch Global Registry for Patients with Peripheral T-Cell Lymphoma at the American Society of Hematolo...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
30/11/200922h07Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
30/11/200914h00Business WireAllos Therapeutics Announces Issuance of U.S. Patent for FOLOTYNNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
23/11/200912h38MarketwiredRidgewater Equity Reviews the Following Equities Human Genome Sciences Inc., Intuit Inc., Advanced Battery Technologies, Linn EnNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
11/11/200914h00Business WireAllos Therapeutics Announces New Data on FOLOTYN™ to be Presented at the American Society of Hematology MeetingNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
11/11/200912h54MarketwiredAnalystChoice.com Provides Analytical Coverage on ELNK, NWSA, NTAP, ALTH, HANS and BPOPNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
10/11/200915h51Business WireAllos Therapeutics to Present at Upcoming Conferences in NovemberNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
03/11/200922h11Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
03/11/200922h01Business WireAllos Therapeutics Reports Third Quarter 2009 Financial ResultsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
02/11/200911h12MarketwiredGlobal Market Perspective Review on ALTH, CINF, ALKS, DBRN, APOL and INFY from TheFortuneFinancial.comNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
26/10/200913h00Business WireAllos Therapeutics to Report Third Quarter 2009 Results on November 3, 2009NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
22/10/200912h57MarketwiredBenchmarkJournal.com Provides Sector & Company Analysis on OMC, PSE, PWR, ALTH, NWSA and ELNKNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
13/10/200922h05Business WireAllos Therapeutics Announces Closing of Public OfferingNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
13/10/200912h40MarketwiredELNK, HERO, ABAT, NTAP, DBRN and ALTH Receives Analytical Coverage from WallStSense.comNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
07/10/200923h08Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(5) (424B5)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
07/10/200912h19Edgar (US Regulatory)Free Writing Prospectus - Filing under Securities Act Rules 163/433 (FWP)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
07/10/200912h14Business WireAllos Therapeutics Announces Pricing of Public Offering of Common StockNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/10/200922h01Business WireAllos Therapeutics Announces Proposed Public Offering of Common StockNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/10/200913h00Business WireAllos Therapeutics Announces U.S. Availability of FOLOTYN™ (pralatrexate injection) for Relapsed or Refractory Peripheral T...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
02/10/200923h53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
01/10/200912h36MarketwiredRothmanResearch.com Stock Review for SCG, CA, NE, MKC, COL and ALTHNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
25/09/200913h00Business WireAllos Therapeutics’ FOLOTYN™ First and Only FDA-Approved Therapy for Relapsed or Refractory Peripheral T-cell LymphomaNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
11/09/200922h15Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
03/09/200900h09Business WireAllos Therapeutics Announces FDA Advisory Committee Recommends Accelerated Approval of FOLOTYN™ (pralatrexate) for the Trea...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
02/09/200912h00Edgar (US Regulatory)Notice of Effectiveness (EFFECT)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
01/09/200915h05Edgar (US Regulatory)Post-Effective Amendment to Registration Statement (POS AM)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
01/09/200914h00Business WireAllos Therapeutics to Hold Post Advisory Committee Conference CallNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
31/08/200915h31PR Newswire (US)Seven Summits Research Releases Comments on Boeing, Joy Global, Ciena Corporation, TakeTwo Interactive and Allos TherapeuticsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
28/08/200919h27Dow Jones NewsFDA Has Several Issues With Allos Data For FolotynNASDAQ:ALTHAllos Therapeutics Inc.
14/08/200922h16Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:ALTH

Dernières Valeurs Consultées

EU
HO
Thales
EU
DG
Vinci
EU
BN
Danone
NASDAQ
MSFT
Microsoft
EU
ML
Michelin
EU
BEL20
Bel 20
USI
USTECH100
US Tech 100
NYSE
KO
Coca Cola
EU
ACA
Credit Agricole
EU
VIV
Vivendi
NYSE
DIS
Walt Disney
FTSE
UKX
FTSE 100
EU
PX1
CAC 40
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés